About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Stat3
signal transducer and activator of transcription 3
MGI:103038
204 phenotypes from 16 alleles in 27 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
involves: C57BL/6
abnormal T-helper 17 cell differentiation J:205858
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
Tg(Agrp-cre)1Gsb/?
involves: C57BL/6 * FVB/N
abnormal glucose homeostasis J:133218
decreased circulating adrenaline level J:133218
decreased circulating glucose level J:133218
decreased circulating insulin level J:133218
decreased circulating noradrenaline level J:133218
decreased gonadal fat pad weight J:133218
improved glucose tolerance J:133218
increased locomotor activity J:133218
increased oxygen consumption J:133218
polyphagia J:133218
slow postnatal weight gain J:133218
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
Tg(Cd4-cre)1Cwi/0
involves: C57BL/6 * DBA/2
decreased lung compliance J:205858
increased airway resistance J:205858
increased circulating interleukin-17 level J:205858
increased interleukin-17 secretion J:205858
increased lung elastance J:205858
increased regulatory T cell number J:205858
increased T-helper 1 cell number J:205858
increased T-helper 17 cell number J:205858
lung inflammation J:205858
premature death J:205858
Stat3tm1Aki/Stat3tm1Aki
involves: 129P2/OlaHsd
absent mesoderm J:40106
decreased embryo size J:40106
decreased inner cell mass proliferation J:40106
embryonic lethality between implantation and somite formation, complete penetrance J:40106
failure to gastrulate J:40106
Stat3tm1Aki/Stat3tm1Aki
Tg(Tek-cre)12Flv/0
involves: 129P2/OlaHsd * C3H * C57BL/6
abnormal interleukin level J:123351
Stat3tm1Aki/Stat3tm2Aki
Tg(Col1a1-cre)1Kry/0
involves: 129P2/OlaHsd * FVB/N * C57BL/6
abnormal bone ossification J:144906
abnormal bone structure J:144906
decreased trabecular bone thickness J:144906
Stat3tm1Aki/Stat3tm2Aki
Tg(NEFL-cre)50Msd/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * CD-1
abnormal motor neuron morphology J:77229
abnormal neuron physiology J:77229
increased susceptibility to injury J:77229
Stat3tm1Desi/Stat3tm1Desi
involves: 129X1/SvJ * C57BL/6
increased susceptibility to endotoxin shock J:77307
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Cd4-cre)1Cwi/?
involves: 129 * C57BL/6 * DBA/2
abnormal CD4-positive T cell differentiation J:124293
abnormal gut-associated lymphoid tissue morphology J:124293
decreased interleukin-17 secretion J:124293
increased interferon-gamma secretion J:124293
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Cryaa-cre)10Mlr/0
involves: C57BL/6
normal vision/eye phenotype J:88422
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Csf1r-icre)1Jwp/0
involves: 129P2/OlaHsd * C57BL/6 * FVB
abnormal acute inflammation J:156593
abnormal cecum morphology J:156593
abnormal colon morphology J:156593
abnormal inflammatory response J:156593
abnormal intestinal mucosa morphology J:156593
colitis J:156593
colon polyps J:156593
decreased body weight J:156593
decreased locomotor activity J:156593
diarrhea J:156593
increased carcinoma incidence J:156593
increased gastrointestinal tumor incidence J:156593
increased granulocyte number J:156593
increased macrophage cell number J:156593
increased T cell number J:156593
weight loss J:156593
Stat3tm1Dlv/Stat3tm1Dlv
Tg(MMTV-cre)4Mam/0
involves: 129P2/OlaHsd * C57BL/6J * FVB
decreased T-helper 17 cell number J:120176
Stat3tm1Dnl/Stat3tm1Dlv
involves: C57BL/6
abnormal circulating insulin-like growth factor I level J:87599
decreased body size J:87599
decreased body weight J:87599
decreased growth hormone level J:87599
decreased thymocyte number J:87599
decreased urine protein level J:87599
fetal growth retardation J:87599
increased thymocyte apoptosis J:87599
postnatal growth retardation J:87599
postnatal lethality, incomplete penetrance J:87599
Stat3tm1Dnl/Stat3tm1Dnl
involves: C57BL/6
no abnormal phenotype detected J:87599
Stat3tm1Flv/Stat3tm1Flv
Tg(Nes-cre)1Kln/0
involves: C57BL/6 * SJL
abnormal body temperature homeostasis J:89242
abnormal brown adipose tissue morphology J:89242
abnormal glucose homeostasis J:89242
abnormal white adipose tissue morphology J:89242
absent corpus luteum J:89242
anovulation J:89242
decreased body length J:89242
decreased body temperature J:89242
decreased energy expenditure J:89242
decreased food intake J:89242
enlarged liver J:89242
female infertility J:89242
hepatic steatosis J:89242
hyperglycemia J:89242
impaired adaptive thermogenesis J:89242
impaired glucose tolerance J:89242
increased circulating corticosterone level J:89242
increased circulating insulin level J:89242
increased circulating leptin level J:89242
increased circulating triglyceride level J:89242
increased total body fat amount J:89242
insulin resistance J:89242
male infertility J:89242
neonatal lethality, incomplete penetrance J:89242
obese J:89242
polyphagia J:89242
short uterine horn J:89242
small seminal vesicle J:89242
small testis J:89242
Stat3tm1Flv/Stat3tm1Flv
Tg(Tek-cre)1Xyfu/0
involves: C57BL/6
abnormal cytokine secretion J:86655
increased susceptibility to endotoxin shock J:86655
Stat3tm1Flv/Stat3tm1Flv
Tg(Tek-cre)12Flv/0
involves: 129 * C3H * C57BL/6
abnormal cecum morphology J:81973
abnormal colon morphology J:81973
abnormal ileum morphology J:81973
abnormal inflammatory response J:81973
abnormal innate immunity J:81973
abnormal intestine morphology J:81973
abnormal T-helper 1 physiology J:81973
cecum inflammation J:81973
colitis J:81973
decreased body size J:81973
decreased body weight J:81973
decreased NAD(P)H oxidase activity J:81973
granulomatous inflammation J:81973
ileum inflammation J:81973
increased circulating interferon-gamma level J:81973
increased circulating tumor necrosis factor level J:81973
increased leukocyte cell number J:81973
intestinal inflammation J:81973
intestinal ulcer J:81973
liver inflammation J:81973
premature death J:81973
weakness J:81973
Stat3tm1Jbha/Stat3tm1Jbha
Tg(Fabp4-cre)1Rev/0
involves: 129S/SvEv * C57BL/6
decreased circulating adiponectin level J:136030
increased body weight J:136030
increased brown adipose tissue amount J:136030
increased fat cell size J:136030
increased gonadal fat pad weight J:136030
increased inguinal fat pad weight J:136030
increased liver weight J:136030
increased percent body fat/body weight J:136030
increased retroperitoneal fat pad weight J:136030
increased total body fat amount J:136030
Stat3tm1Vpo/Stat3+
Tg(Myh6-cre)2182Mds/0
involves: 129P2/OlaHsd * FVB/N
cardiomyopathy J:141591
congestive heart failure J:141591
generalized edema J:141591
pregnancy-related premature death J:141591
Stat3tm1Vpo/Stat3tm1Vpo
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129P2/OlaHsd * C57BL/6 * DBA
increased incidence of tumors by chemical induction J:172422
Stat3tm1Vpo/Stat3tm1Vpo
Tg(Mx1-cre)1Cgn/0
involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CBA
abnormal macrophage physiology J:89194
increased interleukin-6 secretion J:89194
increased tumor necrosis factor secretion J:89194
Stat3tm1Vpo/Stat3tm1Vpo
Tg(Myh6-cre)2182Mds/0
involves: 129P2/OlaHsd * FVB/N
abnormal angiogenesis J:141591
abnormal atrial thrombosis J:141591
abnormal heart echocardiography feature J:141591
abnormal myocardial fiber morphology J:141591
cardiac fibrosis J:141591
cardiomyopathy J:141591
congestive heart failure J:141591
decreased cardiac muscle contractility J:141591
dilated heart J:141591
dilated heart left ventricle J:141591
generalized edema J:141591
increased cardiomyocyte apoptosis J:141591
oxidative stress J:141591
pregnancy-related premature death J:141591
Stat3tm1Vpo/Stat3tm2Vpo
Tg(Mx1-cre)1Cgn/0
involves: C57BL/6 * CBA * BALB/cAn
abnormal macrophage physiology J:89194
increased interleukin-6 secretion J:89194
increased tumor necrosis factor secretion J:89194
Stat3tm1Xyfu/Stat3+
involves: 129S1/Sv * C57BL/6
increased susceptibility to induced morbidity/mortality J:128719
Stat3tm1Xyfu/Stat3+
Tg(Myh6-cre)2182Mds/0
involves: 129S1/Sv * FVB/N
cardiac fibrosis J:86400
increased susceptibility to endotoxin shock J:86400
increased tumor necrosis factor secretion J:86400
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Myh6-cre)2182Mds/0
involves: 129S1/Sv * FVB/N
abnormal cardiovascular system physiology J:86400
ascites J:86400
cachexia J:86400
cardiac fibrosis J:86400
congestive heart failure J:86400
decreased cardiac muscle contractility J:86400
dilated heart J:86400
enlarged heart J:86400
increased cardiomyocyte apoptosis J:86400
increased heart left ventricle size J:86400
increased physiological sensitivity to xenobiotic J:86400
increased susceptibility to endotoxin shock J:86400
increased tumor necrosis factor secretion J:86400
respiratory distress J:86400
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Ttr-cre)10-3Xyfu/?
involves: 129S1/Sv * C57BL/6
decreased hepatocyte proliferation J:128719
increased monocyte cell number J:128719
increased neutrophil cell number J:128719
increased susceptibility to induced morbidity/mortality J:128719
Stat3tm2Aki/Stat3tm2Aki
involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N
abnormal eating behavior J:131301
increased body length J:131301
increased circulating glucose level J:131301
increased circulating insulin level J:131301
obese J:131301
normal reproductive system phenotype J:131301
Stat3tm2Aki/Stat3tm2Aki
involves: 129P2/OlaHsd * BALB/c * C57BL/6
abnormal response to infection J:122213
Stat3tm2Aki/Stat3tm2Aki
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129P2/OlaHsd * 129S4/SvJaeSor
no abnormal phenotype detected J:226497
Stat3tm2Aki/Stat3tm2Aki
Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * C57BL/6
abnormal colon morphology J:83280
colitis J:83280
increased CD4-positive, alpha-beta T cell number J:83280
increased dendritic cell number J:83280
increased interferon-gamma secretion J:83280
increased interleukin-12 secretion J:83280
increased macrophage cell number J:83280
Stat3tm2Aki/Stat3tm2Aki
Tg(Alb1-cre)1Dlr/0
involves: 129P2/OlaHsd * FVB/N
abnormal glucose homeostasis J:109359
Stat3tm2Aki/Stat3tm2Aki
Tg(KRT5-cre)1Tak/0
involves: 129P2/OlaHsd * C3H * C57BL/6
abnormal eye morphology J:194832
abnormal hair cycle anagen phase J:65302
abnormal hair follicle morphology J:65302
acanthosis J:65302
conjunctivitis J:194832
decreased hair follicle number J:65302
decreased keratinocyte migration J:65302
dermatitis J:194832
hyperkeratosis J:65302
impaired wound healing J:65302
lacrimal gland inflammation J:194832
skin fibrosis J:65302
spontaneous skin ulceration J:65302
Stat3tm2Aki/Stat3tm2Aki
Tg(KRT5-cre/ERT2)AJdg/0
involves: 129P2/OlaHsd * FVB/N
abnormal epidermal layer morphology J:138529
decreased incidence of tumors by chemical induction J:138529
increased apoptosis J:138529
Stat3tm2Aki/Stat3tm2Aki
Tg(Lck-cre)1Jtak/0
involves: 129P2/OlaHsd
decreased T cell proliferation J:50443
increased T cell apoptosis J:50443
Stat3tm2Aki/Stat3tm2Aki
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
involves: 129 * 129P2/OlaHsd * C57BL/6
abnormal cytokine level J:87622
abnormal lung vasculature morphology J:87622
abnormal pulmonary alveolus epithelial cell morphology J:87622
abnormal respiratory mechanics J:87622
abnormal surfactant secretion J:87622
decreased lung compliance J:87622
decreased type II pneumocyte number J:87622
increased airway resistance J:87622
increased lung elastance J:87622
increased lung tissue damping J:87622
increased susceptibility to injury J:87622
lung inflammation J:87622
normal mortality/aging J:87622
pulmonary epithelial necrosis J:87622
pulmonary hyaline membrane formation J:87622
respiratory distress J:87622
respiratory failure J:87622
normal respiratory system phenotype J:87622
Stat3tm2Vpo/Stat3tm2Vpo
involves: C57BL/6 * CBA * BALB/cAn
perinatal lethality, complete penetrance J:89194
Stat3tm3Vpo/Stat3tm3Vpo
involves: C57BL/6 * CBA * BALB/cAn
abnormal macrophage physiology J:89194
Stat3tm4Vpo/Stat3tm4Vpo
involves: 129P2/OlaHsd * BALB/cAn
preweaning lethality, complete penetrance J:157976
Tg(KRT5-Stat3*A661C*N663C)1Jdg/0
involves: FVB
abnormal skin morphology J:95458
absent epidermis stratum granulosum J:95458
acanthosis J:95458
hyperkeratosis J:95458
increased keratinocyte proliferation J:95458
mixed cellular infiltration to dermis J:95458
parakeratosis J:95458
psoriasis J:95458
reddish skin J:95458
scaly skin J:95458
thick skin J:95458
Tg(Stat3*)9199Alau/0
involves: C57BL/6
abnormal CD4-positive, alpha-beta T cell physiology J:210877
abnormal T-helper 17 cell differentiation J:210877
decreased IgG1 level J:210877
decreased IgG3 level J:210877
increased IgE level J:210877
increased inflammatory response J:210877
increased neutrophil cell number J:210877
increased susceptibility to bacterial infection J:210877
increased susceptibility to bacterial infection induced morbidity/mortality J:210877
increased susceptibility to endotoxin shock J:210877
intestinal inflammation J:210877

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory